Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood: A pediatric oncology group study
- 1 September 1993
- Vol. 72 (5) , 1790-1794
- https://doi.org/10.1002/1097-0142(19930901)72:5<1790::aid-cncr2820720545>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A pediatric oncology group phase II studyCancer, 1993
- IfosamideJNCI Journal of the National Cancer Institute, 1988
- Clinical trial of etoposide (VP-16) in children with recurrent malignant solid tumorsInvestigational New Drugs, 1988
- Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.Journal of Clinical Oncology, 1987
- Mesna—a short reviewCancer Treatment Reviews, 1987
- DECHLOROETHYLATION OF IFOSFAMIDE AND NEUROTOXICITYThe Lancet, 1986
- Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.Journal of Clinical Oncology, 1986
- Prediction of Ifosfamide/Mesna associated encephalopathyEuropean Journal of Cancer and Clinical Oncology, 1986